Showing results (141-150 of 314) with videos related to

Sort By:
Pageof 32
Plos One|December 3, 2010
Exploring the link between germline and somatic genetic alterations in breast carcinogenesisNúria Bonifaci, Bohdan Górski, Bartlomiej Masojć, et al.
Cancer Research and Treatment|January 5, 2016
Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic CancerMarcin R Lener, Rodney J Scott, Anna Wiechowska-Kozłowska, et al.
JCO Precision Oncology|April 20, 2022
Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2Wojciech Kluźniak, Agata Szymiczek, Amelie Rodrigue, et al.
Cancers|November 13, 2025
Serum Iodine Levels and 8-Year Survival in Patients After Kidney Cancer DiagnosisElżbieta Złowocka-Perłowska, Piotr Baszuk, Adam Kiljańczyk, et al.
Cancer Research|April 17, 2004
A novel founder CHEK2 mutation is associated with increased prostate cancer riskCezary Cybulski, Tomasz Huzarski, Bohdan Górski, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 25, 2020
Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish populationKarolina Malińska, Jakub Deptuła, Emilia Rogoża-Janiszewska, et al.
Nutrients|April 3, 2021
Serum Selenium Level Predicts 10-Year Survival after Breast CancerMarek Szwiec, Wojciech Marciniak, Róża Derkacz, et al.
International Journal of Molecular Sciences|March 14, 2026
All-Cause Mortality and Cancer Risk Dependent on Blood Se Level and HRG rs10770 Genotypes on a Prospective Cohort of Women with Familial Breast CancersKrzysztof Lubiński, Adam Stachowski, Wojciech Marciniak, et al.
Hereditary Cancer in Clinical Practice|January 1, 2020
Serum selenium level and cancer risk: a nested case-control studySteven A Narod, Tomasz Huzarski, Anna Jakubowska, et al.
Pageof 32